These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 27465576

  • 1. Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.
    Hiroi S, Shimasaki Y, Kikuchi T, Otsuka Y, Iwasaki K, Ohishi M.
    Hypertens Res; 2016 Dec; 39(12):907-912. PubMed ID: 27465576
    [Abstract] [Full Text] [Related]

  • 2. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R, Michailidis P.
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [Abstract] [Full Text] [Related]

  • 3. Current use of antihypertensive drugs in Japanese patients with hypertension: Analysis by age group.
    Ishida T, Oh A, Hiroi S, Shimasaki Y, Tsuchihashi T.
    Geriatr Gerontol Int; 2018 Jun; 18(6):899-906. PubMed ID: 29508499
    [Abstract] [Full Text] [Related]

  • 4. Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study.
    Ohishi M, Yoshida T, Oh A, Hiroi S, Takeshima T, Otsuka Y, Iwasaki K, Shimasaki Y.
    Hypertens Res; 2019 Jul; 42(7):1057-1067. PubMed ID: 30842611
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy.
    Wen X, Otoo MN, Tang J, Brothers T, Ward KE, Asal N, Meador KJ.
    JAMA Neurol; 2024 Aug 01; 81(8):866-874. PubMed ID: 38884986
    [Abstract] [Full Text] [Related]

  • 6. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
    Lu Y, Van Zandt M, Liu Y, Li J, Wang X, Chen Y, Chen Z, Cho J, Dorajoo SR, Feng M, Hsu MH, Hsu JC, Iqbal U, Jonnagaddala J, Li YC, Liaw ST, Lim HS, Ngiam KY, Nguyen PA, Park RW, Pratt N, Reich C, Rhee SY, Sathappan SMK, Shin SJ, Tan HX, You SC, Zhang X, Krumholz HM, Suchard MA, Xu H.
    JAMA Netw Open; 2022 Mar 01; 5(3):e223877. PubMed ID: 35323951
    [Abstract] [Full Text] [Related]

  • 7. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL.
    J Am Pharm Assoc (2003); 2010 Mar 01; 50(5):e116-25. PubMed ID: 20833609
    [Abstract] [Full Text] [Related]

  • 8. Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018.
    Hou W, Li D, Shen S, Lin J, Lou A, Wen A.
    Clin Ther; 2021 Mar 01; 43(3):602-612. PubMed ID: 33637331
    [Abstract] [Full Text] [Related]

  • 9. Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension.
    Doege C, Luedde M, Kostev K.
    JAMA Neurol; 2022 Dec 01; 79(12):1296-1302. PubMed ID: 36251288
    [Abstract] [Full Text] [Related]

  • 10. Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up.
    Jeong HS, Lim HS, Park HJ, Lee WS, Choi JO, Lee HS, Jo SH, Hong SJ.
    Sci Rep; 2021 Jan 19; 11(1):1783. PubMed ID: 33469103
    [Abstract] [Full Text] [Related]

  • 11. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.
    Ishida T, Oh A, Hiroi S, Shimasaki Y, Nishigaki N, Tsuchihashi T.
    Hypertens Res; 2019 Feb 19; 42(2):249-256. PubMed ID: 30443023
    [Abstract] [Full Text] [Related]

  • 12. Treatment patterns of antihypertensive fixed-dose combinations according to age and number of agents prescribed: Retrospective analysis using a Japanese claims database.
    Ishida T, Oh A, Nishigaki N, Tsuchihashi T.
    Geriatr Gerontol Int; 2019 Nov 19; 19(11):1077-1083. PubMed ID: 31436025
    [Abstract] [Full Text] [Related]

  • 13. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.
    Ann Cardiol Angeiol (Paris); 2012 Jun 19; 61(3):218-23. PubMed ID: 22695025
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive treatment for hypertensive patients with heart failure using real-world Japanese data: subanalysis of the Retrospective study of antihypertensives for lowering blood pressure (REAL) study.
    Ohishi M, Yoshida T, Nishigaki N, Oh A, Shimasaki Y.
    Clin Exp Hypertens; 2020 Jun 19; 42(2):139-145. PubMed ID: 30912679
    [Abstract] [Full Text] [Related]

  • 15. Real-World Effectiveness of Beta-Blockers versus Other Antihypertensives in Reducing All-Cause Mortality and Cardiovascular Events.
    Foch C, Allignol A, Hostalek U, Boutmy E, Hohenberger T.
    Int J Clin Pract; 2022 Jun 19; 2022():6124559. PubMed ID: 35989866
    [Abstract] [Full Text] [Related]

  • 16. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS, Tang CH, Lin CY, Chuang PY, Chen NC, Huang CH, Chang WT, Wang TD, Yu PH, Chen WJ.
    Cardiovasc Drugs Ther; 2017 Dec 19; 31(5-6):535-543. PubMed ID: 29218625
    [Abstract] [Full Text] [Related]

  • 17. Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study.
    Yang R, Tang J, Kuang M, Liu H.
    Ann Med; 2023 Dec 19; 55(1):276-284. PubMed ID: 36594446
    [Abstract] [Full Text] [Related]

  • 18. Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy.
    Kuriyama S, Tomonari H, Tokudome G, Horiguchi M, Hayashi H, Kobayashi H, Ishikawa M, Hosoya T.
    Hypertens Res; 2002 Nov 19; 25(6):849-55. PubMed ID: 12484508
    [Abstract] [Full Text] [Related]

  • 19. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities.
    Ishida T, Oh A, Hiroi S, Shimasaki Y, Tsuchihashi T.
    Clin Exp Hypertens; 2019 Nov 19; 41(3):203-210. PubMed ID: 29781721
    [Abstract] [Full Text] [Related]

  • 20. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
    Hsiao FC, Tung YC, Chou SH, Wu LS, Lin CP, Wang CL, Lin YS, Chang CJ, Chu PH.
    Medicine (Baltimore); 2015 Dec 19; 94(51):e2355. PubMed ID: 26705234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.